Is BPC-157 legal in Norway?

BPC-157 is among the peptides readers most often ask about in Norway. This page focuses on the regulatory reality there, not on how to obtain or use it, because that is where reliable, localized information is hardest to find.

In Norway, BPC-157 has no marketing authorisation and is not an approved medicine anywhere in the world. It circulates online as a “research chemical” or “not for human use” product. That label does not make human use lawful or safe.

Importing BPC-157 into Norway, including for personal use, is restricted, because it is an unauthorised medicine; customs may detain shipments. A “for research use only” label does not legalise import for human use. Personal possession of BPC-157 in Norway sits in a grey area: it is not a scheduled controlled substance, so simple possession is generally not a drug-scheduling offence, but it is an unauthorised medicine and enforcement targets sale and supply.

BPC-157 is on the WADA Prohibited List (S0, non-approved substances), so it is banned in sport at all times for competing athletes. That is an independent reason for caution regardless of local medicines law.

Selling or supplying BPC-157 without the required authorisation is an offence in Norway. DMP (Norwegian Medical Products Agency, formerly Statens legemiddelverk) sets out the applicable sanctions; we do not reproduce specific figures here because they change. Confirm the current penalties with the regulator. This page reflects our reading of the position as of the last-verified date; regulations change, so confirm with DMP (Norwegian Medical Products Agency, formerly Statens legemiddelverk) before making any decision.